drugset / Trial / NCT00372333

IDEA-033 Open Label Study

NCT00372333

Phase 3 Completed 491 enrolled IDEA AG
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The main aim of the study is to evaluate safety, efficacy, compliance, and usage of epicutaneously applied IDEA-033 in joint / musculoskeletal pain or soft tissue inflammation.

Timeline

Start
2004-08
Primary completion
2007-12
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoprofen Small molecule Topical

Indications